Moon JH - Search Results

1

Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia.

Zheng Q, Cao J, Hamad N, Kim HJ, Moon JH, Sohn SK, Jung CW, Lipton JH, Kim DD. Zheng Q, et al. Among authors: moon jh. J Transl Med. 2016 Mar 24;14:82. doi: 10.1186/s12967-016-0837-5. J Transl Med. 2016. PMID: 27009330 Free PMC article.

2

Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia.

Sohn SK, Oh SJ, Kim BS, Ryoo HM, Chung JS, Joo YD, Bang SM, Jung CW, Kim DH, Yoon SS, Kim H, Lee HG, Won JH, Min YH, Cheong JW, Park JS, Eom KS, Hyun MS, Kim MK, Kim H, Park MR, Park J, Kim CS, Kim HJ, Kim YK, Park EK, Zang DY, Jo DY, Moon JH, Park SY. Sohn SK, et al. Among authors: moon jh. Leuk Lymphoma. 2011 Jun;52(6):1024-9. doi: 10.3109/10428194.2011.563885. Epub 2011 Apr 4. Leuk Lymphoma. 2011. PMID: 21463107 Clinical Trial.

3

Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients.

Moon JH, Sohn SK, Kim SN, Park SY, Yoon SS, Kim IH, Kim HJ, Kim YK, Min YH, Cheong JW, Kim JS, Jung CW, Kim DH. Moon JH, et al. Med Oncol. 2012 Jun;29(2):1179-85. doi: 10.1007/s12032-011-9926-8. Epub 2011 Apr 7. Med Oncol. 2012. PMID: 21472487

4

A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.

Kim DH, Lee ST, Won HH, Kim S, Kim MJ, Kim HJ, Kim SH, Kim JW, Kim HJ, Kim YK, Sohn SK, Moon JH, Jung CW, Lipton JH. Kim DH, et al. Among authors: moon jh. Blood. 2011 Jun 23;117(25):6906-11. doi: 10.1182/blood-2011-01-329797. Epub 2011 May 3. Blood. 2011. PMID: 21540461 Free article.

5

Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer.

Kang BW, Kim JG, Chae YS, Lee YJ, Lee SJ, Moon JH, Sohn SK, Jung MK, Jeon SW, Jang YJ, Seo J, Lee YH, Kwon O, Chung HY, Yu W. Kang BW, et al. Among authors: moon jh. Invest New Drugs. 2012 Aug;30(4):1671-5. doi: 10.1007/s10637-011-9729-y. Epub 2011 Aug 17. Invest New Drugs. 2012. PMID: 21845514 Clinical Trial.

6

Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast.

Moon JH, Lee SJ, Lee YJ, Kang BW, Chae YS, Kim JG, Suh JS, Sohn SK. Moon JH, et al. Ann Hematol. 2012 Mar;91(3):367-73. doi: 10.1007/s00277-011-1321-1. Epub 2011 Sep 27. Ann Hematol. 2012. PMID: 21947085

7

No Association of Insulin-like Growth Factor Gene Polymorphisms with Survival in Patients with Colorectal Cancer.

Cho YY, Kim JG, Chae YS, Sohn SK, Kang BW, Moon JH, Jeon SW, Park JS, Park JY, Choi GS. Cho YY, et al. Among authors: moon jh. Cancer Res Treat. 2011 Sep;43(3):189-94. doi: 10.4143/crt.2011.43.3.189. Epub 2011 Sep 30. Cancer Res Treat. 2011. PMID: 22022297 Free PMC article.

8

Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype.

Yi JH, Huh J, Kim HJ, Kim SH, Kim HJ, Kim YK, Sohn SK, Moon JH, Kim SH, Kim KH, Won JH, Mun YC, Kim H, Park J, Jung CW, Kim DH. Yi JH, et al. Among authors: moon jh. J Clin Oncol. 2011 Dec 10;29(35):4702-8. doi: 10.1200/JCO.2011.35.5719. Epub 2011 Nov 14. J Clin Oncol. 2011. PMID: 22084373

9

Prospective Randomization Trial of G-CSF-Primed Induction Regimen versus Standard Regimen in Patients with AML.

Lee YJ, Moon JH, Kim JG, Chae YS, Kang BW, Lee SJ, Choi JY, Shin HC, Seo JW, Sohn SK. Lee YJ, et al. Among authors: moon jh. Chonnam Med J. 2011 Aug;47(2):80-4. doi: 10.4068/cmj.2011.47.2.80. Epub 2011 Aug 31. Chonnam Med J. 2011. PMID: 22111065 Free PMC article.

10

A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma.

Ahn JS, Yang DH, Jung SH, Park HC, Moon JH, Sohn SK, Bae SY, Kim YK, Kim HJ, Lee JJ; Korean Multiple Myeloma Working Party (KMMWP). Ahn JS, et al. Among authors: moon jh. Ann Hematol. 2012 Jul;91(7):1023-30. doi: 10.1007/s00277-012-1420-7. Ann Hematol. 2012. PMID: 22314843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,679 results

Search Page